文献速递神经肿瘤

PTRF/cavin-1通过稳定cPLA2重塑磷脂代谢促进胶质母细胞瘤增殖并抑制免疫应答

PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
PubMed 文献 · Neuro Oncol · 2021-01-01

该研究探讨PTRF/cavin-1在胶质母细胞瘤(GBM)代谢重塑中的作用。通过非靶向代谢组学和脂质组学分析,结合体外实验及异种移植与颅内肿瘤小鼠模型,发现PTRF通过稳定cPLA2增强其活性,重塑磷脂组成,促进肿瘤增殖并减少CD8+肿瘤浸润淋巴细胞;抑制cPLA2可阻断上述效应。

要点

  • PTRF通过增加cPLA2蛋白稳定性增强其活性,重塑GBM磷脂代谢。
  • PTRF过表达改变GBM细胞内吞能力和能量代谢。
  • 抑制cPLA2可阻断肿瘤增殖并防止PTRF诱导的CD8+ T细胞减少。

核心结论

  • PTRF-cPLA2脂质重塑通路促进GBM肿瘤增殖并抑制免疫应答。
  • 该通路提示GBM多个新的治疗靶点。

研究设计与样本

  • 采用非靶向代谢组学及脂质组学分析PTRF与GBM脂质代谢的关系。
  • 运用Western blotting、定量实时PCR和免疫沉淀探索PTRF在脂质代谢中的分子机制。
  • 通过体外实验及异种移植瘤和颅内肿瘤小鼠模型检测PTRF的肿瘤特异性影响。
  • 研究使用GBM患者原代细胞系。

主要发现

  • 过表达PTRF的GBM患者原代细胞系显示cPLA2活性增加,源于蛋白稳定性增加,并呈现重塑的磷脂组成。
  • PTRF过表达改变GBM细胞的内吞能力和能量代谢。
  • 在GBM异种移植和颅内肿瘤小鼠模型中,抑制cPLA2活性可阻断肿瘤增殖并防止PTRF诱导的CD8+肿瘤浸润淋巴细胞减少。

临床怎么用

  • 靶向PTRF-cPLA2脂质重塑通路可能成为GBM治疗策略。
  • 抑制cPLA2活性可能同时抑制肿瘤增殖并恢复CD8+ T细胞浸润。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolism remodeling is a hallmark of glioblastoma (GBM) that regulates tumor proliferation and the immune microenvironment. Previous studies have reported that increased polymerase 1 and transcript release factor (PTRF) levels are associated with a worse prognosis in glioma patients. However, the biological role and the molecular mechanism of PTRF in GBM metabolism remain unclear. METHODS: The relationship between PTRF and lipid metabolism in GBM was detected by nontargeted metabolomics profiling and subsequent lipidomics analysis. Western blotting, quantitative real-time PCR, and immunoprecipitation were conducted to explore the molecular mechanism of PTRF in lipid metabolism. A sequence of in vitro and in vivo experiments (both xenograft tumor and intracranial tumor mouse models) were used to detect the tumor-specific impacts of PTRF. RESULTS: Here, we show that PTRF triggers a cytoplasmic phospholipase A2 (cPLA2)-mediated phospholipid remodeling pathway that promotes GBM tumor proliferation and suppresses tumor immune responses. Research in primary cell lines from GBM patients revealed that cells overexpressing PTRF show increased cPLA2 activity-resulting from increased protein stability-and exhibit remodeled phospholipid composition. Subsequent experiments revealed that PTRF overexpression alters the endocytosis capacity and energy metabolism of GBM cells. Finally, in GBM xenograft and intracranial tumor mouse models, we showed that inhibiting cPLA2 activity blocks tumor proliferation and prevents PTRF-induced reduction in CD8+ tumor-infiltrating lymphocytes. CONCLUSIONS: The PTRF-cPLA2 lipid remodeling pathway promotes tumor proliferation and suppresses immune responses in GBM. In addition, our findings highlight multiple new therapeutic targets for GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Yi K, Zhan Q, Wang Q, et al. PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2. Neuro Oncol. 2021. PMID: 33140095. doi:10.1093/neuonc/noaa255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。